Sketch a Day vs Sketchar

Sketch a Day is a drawing app and art community for beginners and professional artists, with versions for iOS and Android. It supplies hand-picked daily prompts that users can draw from, then compare, like, favourite and share their work. Free tutorials from professional artists help users build skills, while community members contribute tutorials and exchange tips, hints and feedback in the app. Guided projects and progress tracking are also available. Milestones and streaks let users add famous artworks to a collection and learn about the artists behind them. The free plan costs nothing. Gold membership adds an automatically updated portfolio website, a profile with a header image, bio and website link, private artist chat and an ad-free experience; artists can opt in to being contacted. The privacy policy identifies Firebase Analytics as a third-party service and says absolute security cannot be guaranteed. Users can request data deletion in Settings, and the support team aims to respond to emails within 24–48 hours.

Sketchar is a drawing app that uses augmented reality to place sketches onto real surfaces, including paper, walls and murals. Its digital canvas includes brushes, layers, automatic stroke smoothing, time-lapse recording and a liquid brush. It also offers more than 1,000 lessons in subjects such as anime, portraits, animals and landscapes. For murals, its VR app projects a sketch onto a surface through Meta Quest or Pico headsets and is described as working in daylight without cables or a projector. Listed headsets are Meta Quest 3, 3S and Pro, and Pico 4 Ultra; Apple Vision Pro is described as coming soon. Images can be uploaded to VR through Google Drive, the web app or mobile apps. Downloaded sketches can be used on site without Wi-Fi. Mobile multiplayer supports shared-canvas drawing on iOS and Android with invite links and unlimited participants per room; Meta Quest multiplayer supports up to 10 headsets on one Wi-Fi network. Plans include a free option and paid options, with a 7-day trial.